Your session is about to expire
← Back to Search
Spesolimab for Pustular Psoriasis
Study Summary
This trial is testing spesolimab to see if it can help prevent GPP flare-ups in adolescents and adults.
- Pustular Psoriasis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2020 Phase 2 & 3 trial • 98 Patients • NCT03482635Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Will this research be testing individuals who are octogenarians?
"This study allows for a wide age range of participants, with the minimum being 12 years old and the maximum being 75."
Would I be able to help out with this research project?
"In order to qualify for this clinical trial, potential participants must have a diagnosis of gpp and be between 12-75 years old. There is a total need for 123 individuals in the study."
Are there other drugs that have been studied in combination with Spesolimab?
"To date, there are 5 ongoing clinical trials for Spesolimab with none of them in Phase 3. The highest concentration of research is in Mainz and California; however, you can find 329 different locations running clinical trials related to Spesolimab."
When might Spesolimab be available for public use?
"Spesolimab's safety is based on early data from Phase 2 trials, which only provides limited evidence supporting its usage."
Does this medical research break new ground?
"Spesolimab is being trialed in 37 cities, across 36 countries and there are 5 active trials. The first trial was conducted in 2018 by 79 participants. The sponsor of the study, Boehringer Ingelheim completed its Phase 2 drug approval stage. In total, 18298 have been completed since then."
Are we still receiving volunteers for this experiment?
"Unfortunately, this study is not currently looking for participants. Although the details on clinicaltrials.gov show that it was most recently updated on November 15th, 2022, recruitment for this trial has already concluded. However, there are plenty of other opportunities to get involved in medical research; as of right now, there are 184 other trials enrolling patients."
How many participants are being sought for this research?
"As of now, this clinical trial is not admitting any more patients. This experiment was first posted on June 4th 2020 and was updated on November 15th 2020. If you are looking for other similar studies, there are 179 clinical trials actively recruiting participants who have generalized pustular psoriasis (gpp) and 5 studies for Spesolimab that still need volunteers."
Share this study with friends
Copy Link
Messenger